TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Mar 01, 2019 22:00 JST
Source:
NutraLife Biosciences, Inc.
NutraFuels, Inc. Explores New Delivery Systems with Pharmaceutical GMP Manufacturer
Coconut Creek, FL, Mar 01, 2019 - (ACN Newswire) - via NEWMEDIAWIRE -- NutraFuels, Inc (fka NutraLife Biosciences, Inc) plans to explore additional options for delivery systems for its nutraceutical and wellness products and pharmaceutical delivery systems.
"We are excited to be exploring our capabilities in the life sciences space by engaging in the research and development of more formulations and enhanced delivery systems with an experienced cGMP pharmaceutical manufacturer," said Edgar Ward, CEO and Founder of NutraFuels.
The Company plans to explore these various pharmaceutical formulations and delivery systems while utilizing the valuable experience of a cGMP pharmaceutical manufacturer.
NutraFuels manufactures and distributes private label and its own branded products under its NutraHempCBD and NutraSpray brands. The Company's product development, testing and research are conducted by four chemists under the supervision of Mr. Ward. The Company manufactures 100% of its products at its FDA registered facility in accordance with GMP standards.
NutraFuels, Inc (OTCQB: NTFU) is a fully reporting company with a class of securities registered with the U.S. Securities and Exchange Commission (SEC). As filed with the SEC on November 13, 2018, the Company's financial results for the three (3) and nine (9) month period ended September 30, 2018 saw revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NutraFuels' filings with the SEC can be viewed at www.sec.gov, or on the Company website at www.NutraFuels.com.
NutraFuels' CBD products and information about the company's direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.
Contact:
NutraLife Biosciences, Inc
Coconut Creek, FL 33073
Telephone 1-888-509-8901
http://www.NutraFuels.com
Forward-Looking Statements
This communication contains statements of a forward-looking nature about NutraFuels, Inc (the "Company"). These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. New risk factors emerge from time to time, and it is impossible for the Company's management to predict all risk factors, nor can the Company assess the impact of all factors on Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.
Source: NutraFuels Inc.
Source: NutraLife Biosciences, Inc.
Sectors: Food & Beverage, BioTech, Healthcare & Pharm, Funds & Equities, Cosmetics, Spec.Chem
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
NutraLife Biosciences, Inc. enters Joint Venture with Henning Trading LLC to Cultivate and Process Hemp for 2019 U.S. Grow Season
April 12 2019 07:20 JST
NutraLife Bioscience, Inc. Reports 2018 Year End Financial Results
April 04 2019 05:00 JST
NutraLife Biosciences Encouraged By CVS Health Corporation's Decision to Distribute CBD at 800 Stores in the U.S.
March 25 2019 05:00 JST
NutraLife Bioscience, Inc. Receives License to Grow and Process Industrial Hemp
March 15 2019 05:00 JST
NutraLife Biosciences, Inc. Receives Contract to Provide Its Technologies and Delivery System for Pharmaceutical Products by cGMP Pharmacy
March 13 2019 05:00 JST
NutraFuels, Inc. Tests Confirm High Quality Proprietary Ultra Shear Technology Platform
February 25 2019 09:00 JST
NutraFuels, Inc. Founds NutraDerma Technologies and Acquires Patented All-Natural Skin Patch for Deet-free Mosquito Deterrent
February 13 2019 08:00 JST
NutraFuels and Pressure BioSciences to Collaborate on the Development of Water-Soluble Nanoemulsion-based Nutraceuticals
January 30 2019 22:00 JST
Legalization of Industrial Hemp Positions NutraFuels for Market Expansion
December 21 2018 09:00 JST
NutraFuels, Inc Takes Strides to Becoming Fully-Integrated in the Hemp-Derived CBD Sector, Forms Strategic Partnership with Maryland Based Botanical Products Processor
November 21 2018 08:00 JST
More Press release >>
Latest Press Release
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Dec 12, 2025 11:00 JST
MHI and Worley to Deliver Full-Scale Carbon Capture Facility for Heidelberg Materials UK's Padeswood Cement Works
Dec 08, 2025 17:00 JST
Honda Technical Support for Red Bull Powertrains in F1 Racing Concludes
Dec 08, 2025 16:34 JST
MHIET U.S. Subsidiary's Franklin Plant Celebrates 10th Anniversary
Dec 08, 2025 16:03 JST
Lexus World Premieres Lexus LFA Concept BEV Sports Car
Dec 05, 2025 19:13 JST
TOYOTA GAZOO Racing World Premieres GR GT & GR GT3
Dec 05, 2025 18:58 JST
TOYOTA GAZOO Racing and Lexus Hold World Premiere of GR GT, GR GT3, and Lexus LFA Concept
Dec 05, 2025 18:24 JST
World's First General Design Approval (GDA) for Developed Steel and Post-Weld Heat Treatment (PWHT) Exemption based on ECA for Low-pressure Liquefied CO2 Tank made of KF460 steel
Dec 05, 2025 18:17 JST
Hitachi at CES 2026: Building a Harmonized Society Through Technology
Dec 04, 2025 19:40 JST
Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference
Dec 04, 2025 19:08 JST
NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration
Dec 04, 2025 18:52 JST
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at CTAD 2025
Dec 04, 2025 18:36 JST
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST
New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
Dec 03, 2025 18:19 JST
Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 18:00 JST
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST
Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST
Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
More Latest Release >>